India's Biocon Says Primary Endpoints Set For Oral Insulin May Have Been "Harsh"; Reinforces Goal To Develop Drug With Global Partner

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.